Arivianda M DeSilva (Aravinda M de Silva, Aravinda de Silva)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Advanced Non Small Cell Lung Cancer

Monoclonal Antibody

Top Venues

Nature communications

Science (New York, N.Y.)

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Leah C Katzelnick, Camila Odio, Jedas Daag, Maria Vinna Crisostomo, Charlie J Voirin, Ana Coello Escoto, Cameron Adams, Lindsay Dahora Hein, Rosemary Aogo, Patrick Mpingabo, Guillermo Raimundi Rodriguez, Saba Firdous, Maria Abad Fernandez, Laura White, Kristal-An Agrupis, Jacqueline Deen, Arivianda M DeSilva, Michelle Ylade
Dengue virus IgG and serotype-specific neutralizing antibody titers measured with standard and mature viruses are associated with protection. Research square (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Leah C Katzelnick, Camila Odio, Jedas Daag, Maria Vinna Crisostomo, Charlie J Voirin, Ana Coello Escoto, Cameron Adams, Lindsay Dahora Hein, Rosemary Aogo, Patrick Mpingabo, Guillermo Raimundi Rodriguez, Saba Firdous, Maria Abad Fernandez, Laura White, Kristal-An Agrupis, Jacqueline Deen, Arivianda M DeSilva, Michelle Ylade
Dengue virus IgG and serotype-specific neutralizing antibody titers measured with standard and mature viruses are associated with protection. Research square (2024)
Sandra Bos, Aaron L Graber, Jaime A Cardona-Ospina, Elias M Duarte, Jose Victor Zambrana, Jorge A Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C Katzelnick, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nature communications 15 (1) (2024)
Rita M Meganck, Deanna Zhu, Stephanie Dong, Lisa J Snoderly-Foster, Yago R Dalben, Devina Thiono, Laura J White, Arivianda M DeSilva, Ralph S Baric, Longping V Tse
Evolution of a functionally intact but antigenically distinct DENV fusion loop. eLife 12 (2023)
Cameron Adams, Derek L Carbaugh, Bo Shu, Thiam-Seng Ng, Izabella N Castillo, Ryan Bhowmik, Bruno Segovia-Chumbez, Ana C Puhl, Stephen Graham, Sean A Diehl, Helen M Lazear, Shee-Mei Lok, Arivianda M DeSilva, Lakshmanane Premkumar
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus. PLoS pathogens 19 (1) (2023)
Cameron Adams, Derek L Carbaugh, Bo Shu, Thiam-Seng Ng, Izabella N Castillo, Ryan Bhowmik, Bruno Segovia-Chumbez, Ana C Puhl, Stephen Graham, Sean A Diehl, Helen M Lazear, Shee-Mei Lok, Arivianda M DeSilva, Lakshmanane Premkumar
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika Virus. PLoS pathogens 19 (1) (2023)
Cameron Adams, Derek L Carbaugh, Bo Shu, Thiam-Seng Ng, Izabella N Castillo, Ryan Bhowmik, Bruno Segovia-Chumbez, Ana C Puhl, Stephen Graham, Sean A Diehl, Helen M Lazear, Shee-Mei Lok, Arivianda M DeSilva, Lakshmanane Premkumar
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus. PLoS pathogens 19 (1) (2023)
Cameron Adams, Derek L Carbaugh, Bo Shu, Thiam-Seng Ng, Izabella N Castillo, Ryan Bhowmik, Bruno Segovia-Chumbez, Ana C Puhl, Stephen Graham, Sean A Diehl, Helen M Lazear, Shee-Mei Lok, Arivianda M DeSilva, Lakshmanane Premkumar
Structure and neutralization mechanism of a human antibody targeting a complex Epitope on Zika virus. PLoS pathogens 19 (1) (2023)
Arivianda M DeSilva
Safety of Dengue Vaccine? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Laura J White, Ellen F Young, Mark J Stoops, Sandra R Henein, Elizabeth C Adams, Ralph S Baric, Arivianda M DeSilva
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003). PLoS neglected tropical diseases 15 (3) (2021)
Stephan T Kudlacek, Stefan W Metz, Devina Thiono, Alexander Matthew Payne, Thanh T N Phan, Shaomin Tian, Lawrence J Forsberg, Jack B Maguire, Ian Seim, Shu Zhang, Ashutosh Tripathy, Joseph S Harrison, Nathan I Nicely, Sandrine Soman, Michael K McCracken, Gregory D Gromowski, Richard G Jarman, Lakshmanane Premkumar, Arivianda M DeSilva, Brian Kuhlman
Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies. Science advances 7 (42) (2021)
Jose Mateus, Alba Grifoni, Alison Tarke, John Sidney, Sydney I Ramirez, Jennifer M Dan, Zoe C Burger, Stephen A Rawlings, Davey M Smith, Elizabeth Jane Phillips, Simon A Mallal, Marshall Lammers, Paul Rubiro, Lorenzo Quiambao, Aaron Sutherland, Esther Dawen Yu, Ricardo da Silva Antunes, Jason A Greenbaum, April Frazier, Alena Janda Markmann, Lakshmanane Premkumar, Arivianda M DeSilva, Bjoern Peters, Shane Crotty, Alessandro Sette, Daniela Weiskopf
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science (New York, N.Y.) 370 (6512) (2020)
Yixuan J Hou, Shiho Chiba, Peter J Halfmann, Camille Ehre, Makoto Kuroda, Kenneth H Dinnon Iii, Sarah R Leist, Alexandra Schaefer, Noriko Nakajima, Kenta Takahashi, Rhianna E Lee-Ferris, Teresa M Mascenik, Rachel L Graham, Caitlin E Edwards, Longping V Tse, Kenichi Okuda, Alena Janda Markmann, Luther A Bartelt, Arivianda M DeSilva, David M Margolis, Richard C Boucher, Scott H Randell, Tadaki Suzuki, Lisa E Gralinski, Yoshihiro Kawaoka, Ralph S Baric
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science (New York, N.Y.) 370 (6523) (2020)
Leah C Katzelnick, César Narvaez, Sonia Arguello, Brenda Lopez Mercado, Damaris Collado, Oscarlett Ampie, Douglas Elizondo, Tatiana Miranda, Fausto Bustos Carrillo, Juan Carlos Mercado, Krista Latta, Amy J Schiller, Bruno Segovia-Chumbez, Sergio Ojeda, Nery Sanchez, Miguel Plazaola, Josefina Coloma, M Elizabeth Halloran, Lakshmanane Premkumar, Aubree Gordon, Federico Narvaez, Arivianda M DeSilva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Zika virus infection enhances future risk of severe dengue disease. Science (New York, N.Y.) 369 (6507) (2020)
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R Martinez, Rajendra Raut, Alena Janda Markmann, Caleb Cornaby, Luther Bartelt, Susan Weiss, Yara Park, Caitlin E Edwards, Eric T Weimer, Erin M Scherer, Nadine Rouphael, Srilatha Edupuganti, Daniela Weiskopf, Longping V Tse, Yixuan J Hou, David M Margolis, Alessandro Sette, Matthew H Collins, John L Schmitz, Ralph S Baric, Arivianda M DeSilva
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Science immunology 5 (48) (2020)
Ping Liu, Violetta Weinreb, Marc Ridilla, Laurie Betts, Pratik Patel, Arivianda M DeSilva, Nancy L Thompson, Ken Jacobson
Rapid, directed transport of DC-SIGN clusters in the plasma membrane. Science advances 3 (11) (2017)
Bhumi Patel, Patti Longo, Michael J Miley, Magelda Montoya, Eva Harris, Arivianda M DeSilva
Dissecting the human serum antibody response to secondary dengue virus infections. PLoS neglected tropical diseases 11 (5) (2017)